Abstract
Purpose
Long-term exposure to arsenic above 50 μg/L in drinking water has been related to multiple types of cancers. Few epidemiologic studies conducted in the US have detected an association between regional exposures below this level in drinking water and corresponding cancer occurrence rates. This county-level ecologic study evaluates arsenic levels in ground water and its association with targeted cancer incidence in Idaho, where some regions have been found to contain higher arsenic levels.
Methods
Using cancer incidence data (1991–2005) from the Cancer Data Registry of Idaho and arsenic data (1991–2005) from the Idaho Department of Environmental Quality, we calculated the age-adjusted incidence rate for cancers of the urinary bladder, kidney and renal pelvis, liver and bile duct, lung and bronchus, non-Hodgkin’s lymphoma (NHL), and all malignant cancers according to arsenic levels in ground water. Multivariate regression analysis was applied to evaluate the relationship between arsenic levels in ground water and cancer incidence.
Results
For males, but not for females, age-adjusted incidence for lung cancer and all malignant cancers was significantly higher in the intermediate arsenic counties (2–9 μg/L, n = 16) and the high arsenic counties (≥10 μg/L, n = 5) compared to the low arsenic counties (<2.0 μg/L, n = 23). When adjusted for race, gender, population density, smoking and body mass index (BMI), no relationship was found between arsenic levels in ground water and cancer incidence.
Conclusions
In this ecological design, exposure to low-level arsenic in ground water is not associated with cancer incidence when adjusting for salient variables. For populations residing in southwestern Idaho, where arsenic has been found to exceed 10 μg/L in ground water, individual risk assessment is required in order to determine whether there is a link between long-term arsenic exposure at these levels and cancer risk.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ayotte JD, Baris D, Cantor KP et al (2006) Bladder cancer mortality and private well use in New England: an ecological study. J Epidemiol Community Health 60(2):168–172
Bates MN, Smith AH, Cantor KP (1995) Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 141(6):523–530
Cancer Data Registry of Idaho (2006) Geographic Reports: County Cancer Profile [cited 09 April 2007]
Chappell WR, Beck BD, Brown KG et al (1997) Inorganic arsenic: a need and an opportunity to improve risk assessment. Environ Health Perspect 105(10):1060–1067
Focazio MJ, Welch AH, Watkins SA et al (2000) US Geological Survey. A retrospective analysis on the occurrence of arsenic in ground-water resources of the United States and limitations in drinking-water-supply characterizations. Water-resources investigations Report 99–4279. Prepared in cooperation with the US Environmental Protection Agency Office of Ground Water and Drinking Water
Forman D, Cook-Mozaffari P, Darby S et al (1987) Cancer near nuclear installations. Nature 329(6139):499–505
Gebel T (2000) Confounding variables in the environmental toxicology of arsenic. Toxicology 144(1–3):155–162
Hagan EF (2004) Idaho Department of Water Resources, ground water quality technical brief, statewide ambient ground water quality monitoring program arsenic speciation results (2002 & 2003) [cited 19 March 2007]
Hopenhayn-Rich C, Biggs ML, Smith AH (1998) Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int J Epidemiol 27(4):561–569
Howe GR (1991) Risk of cancer mortality in populations living near nuclear facilities. JAMA 265(11):1438–1439
Huang C, Ke Q, Costa M et al (2004) Molecular mechanisms of arsenic carcinogenesis. Mol Cell Biochem 255(1–2):57–66
Hughes MF (2002) Arsenic toxicity and potential mechanisms of action. Toxicol Lett 133(1):1–16
Johnson CJ, Carson SL (2000) Cancer Data Registry of Idaho, Geographic Reports: cancer trend in Idaho: 1971–1998. [cited 01 May 2007]
Johnson CJ, Mitchell TS (2007) An evaluation of potential association between arsenic concentrations in ground water and 2000–2004 cancer incidence rates in Idaho by Zip code. Cancer Data Registry of Idaho and Department of Environmental Quality. [cited 01 May 2007]
Kapaj S, Peterson H, Liber K et al (2006) Human health effects from chronic arsenic poisoning—a review. J Environ Sci Health A Tox Hazard Subst Environ Eng 41(10):2399–2428
Karagas MR, Tosteson TD, Morris JS et al (2004) Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 15(5):465–472
Kitchin KT (2001) Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 172(3):249–261
Lamm SH, Engel A, Kruse MB et al (2004) Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 US counties and 30 years of observation. J Occup Environ Med 46(3):298–306
Lewis DR, Southwick JW, Ouellet-Hellstrom R et al (1999) Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect 107(5):359–365
Marshall G, Ferreccio C, Yuan Y et al (2007) Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 99(12):920–928
Meliker JR, Slotnick MJ, Avruskin GA et al (2007) Individual lifetime exposure to inorganic arsenic using a space–time information system. Int Arch Occup Environ Health 80(3):184–197
Moore LE, Lu M, Smith AH (2002) Childhood cancer incidence and arsenic exposure in drinking water in Nevada. Arch Environ Health 57(3):201–206
Neely KW (2002) Arsenic results from the statewide program, 1991–2001. [cited 08 May 2007]
Smith AH, Goycolea M, Haque R et al (1998) Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol 147(7):660–669
Steinmaus C, Yuan Y, Bates MN et al (2003) Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol 158(12):1193–1201
Tapio S, Grosche B (2006) Arsenic in the aetiology of cancer. Mutat Res 612(3):215–246
Tchounwou PB, Centeno JA, Patlolla AK (2004) Arsenic toxicity, mutagenesis, and carcinogenesis—a health risk assessment and management approach. Mol Cell Biochem 255(1–2):47–55
United States Bureau of Census (2001) Cartographic Products Management Branch [03 March cited 2007]
United States Bureau of Census (2005) United States Census 2000 summary file [cited 5 May 2007]
United States Environmental Protection Agency (2001) Arsenic in drinking water. Final rule Fed Regist 66(14):7000–7010
Welch AH, A.Watkins S, Helsel DR et al (2007) US Geological Survey. Arsenic in ground-water resources of the United States. USGS Fact Sheet 063-00 2000 [cited 02 March 2007]
Wu MM, Kuo TL, Hwang YH et al (1989) Dose–response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 130(6):1123–1132
Yoshida T, Yamauchi H, Fan Sun G (2004) Chronic health effects in people exposed to arsenic via the drinking water: dose–response relationships in review. Toxicol Appl Pharmacol 198(3):243–252
Acknowledgments
The authors thank Christopher J. Johnson, Epidemiologist from Cancer Data Registry of Idaho, and Lin Campbell, Technical Hydrogeologist from Idaho Department of Water Resources, for providing Idaho cancer registry data and Idaho arsenic data in ground water in Idaho. The authors also thank Professor Ravi Sharma for his comments on GIS methodology.
Conflict of interest statement
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Han, YY., Weissfeld, J.L., Davis, D.L. et al. Arsenic levels in ground water and cancer incidence in Idaho: an ecologic study. Int Arch Occup Environ Health 82, 843–849 (2009). https://doi.org/10.1007/s00420-008-0362-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00420-008-0362-9